In a study to assess the severity of acute pancreatitis, it was discovered that the interleukin-1 receptor antagonist had the best accuracy among many indicators and that interleukin-1 levels suggested severe acute pancreatitis on admission with accuracy similar to that of interleukin-6 (82% and 88%, respectively). This evidence concerns the gene IL6 and acute pancreatitis.